공간 오믹스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Spatial Omics Market size is expected to reach USD 3.41 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 16.81% during 2026-2034.

The Global Spatial Omics Market is experiencing rapid growth due to advancements in genomics and precision medicine. Spatial omics technologies allow researchers to study gene and protein expression within the spatial context of tissues. This approach provides deeper insights into disease mechanisms, especially in cancer research and neuroscience. Increasing funding for life sciences research and the rising demand for personalized medicine are major drivers supporting market expansion.

Pharmaceutical and biotechnology companies are adopting spatial omics to improve drug discovery and development processes. Academic research institutions are also investing heavily in advanced imaging and sequencing technologies. The growing prevalence of chronic diseases, along with the need for accurate diagnostics, is further strengthening demand. Technological advancements in imaging platforms and bioinformatics tools are enhancing data accuracy and research efficiency.

In the coming years, the market is expected to grow significantly as technology becomes more accessible and cost-effective. Collaborations between research institutions and industry players will drive innovation. Expansion in emerging healthcare markets and increased government support for genomic research will create new opportunities. As precision medicine becomes more mainstream, spatial omics will play a vital role in transforming healthcare solutions globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

By Product

• Instruments
• Consumables
• Software

By Workflow

• Sample Preparation
• Instrumental Analysis
• Data Analysis

By Sample Type

• FFPE
• Fresh Frozen

By End-use

• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

COMPANIES PROFILED

• 10x Genomics, BioTechne, Bruker, Dovetail Genomics, S2 Genomics Inc, Akoya Biosciences Inc, RareCyte Inc, Standard BioTools, Rebus Biosystems Inc, Vizgen Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL OMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Spatial Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Spatial Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL OMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL OMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Instrumental Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL OMICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. FFPE Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Fresh Frozen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL OMICS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Academic & Translational Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPATIAL OMICS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Technology
  • 9.2.2 By Product
  • 9.2.3 By Workflow
  • 9.2.4 By Sample Type
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Technology
  • 9.3.2 By Product
  • 9.3.3 By Workflow
  • 9.3.4 By Sample Type
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Technology
  • 9.4.2 By Product
  • 9.4.3 By Workflow
  • 9.4.4 By Sample Type
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Technology
  • 9.5.2 By Product
  • 9.5.3 By Workflow
  • 9.5.4 By Sample Type
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Technology
  • 9.6.2 By Product
  • 9.6.3 By Workflow
  • 9.6.4 By Sample Type
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SPATIAL OMICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 10x Genomics
  • 11.2.2 Bio-Techne
  • 11.2.3 Bruker
  • 11.2.4 Dovetail Genomics
  • 11.2.5 S2 Genomics Inc
  • 11.2.6 Akoya Biosciences Inc
  • 11.2.7 RareCyte Inc
  • 11.2.8 Standard BioTools
  • 11.2.9 Rebus Biosystems Inc
  • 11.2.10 Vizgen Inc